logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

The probability of the Fed keeping interest rates unchanged in June is 99.3%.

date
01/06/2026
According to CME's "Fed Watch": The probability that the Fed will maintain interest rates unchanged by June is 99.3%, and the probability of a cumulative rate hike of 25 basis points is 0.7%. The probability that the Fed will maintain interest rates unchanged by July is 94%, and the probability of a cumulative rate hike of 25 basis points is 5.9%.
Latest
2 m ago
Experts discuss the path of high-quality development of trade: cultivating new productive forces and consolidating the advantages of intermediate goods trade.
2 m ago
China Biologic Pharmaceuticals (01177.HK): The phase III clinical data of pembrolizumab in combination with anlotinib as first-line treatment for non-squamous non-small cell lung cancer will be announced at ASCO in 2026.
2 m ago
Australia's May final S&P Global Manufacturing PMI was 50.7, up from the previous value of 50.2.
4 m ago
IPO news: CheLianTianXia submitted an application to Hong Kong Stock Exchange, ranking third in China's intelligent cockpit domain controller field.
7 m ago
China Biopharmaceuticals (01177): TQB6411 "EGFR/C-MET ADC" to announce Phase I clinical data at ASCO in 2026.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.